CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography platform specifically designed to address the unmet ne... CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. We are initially focused on becoming the standard of care for the detection and management of seizures in the acute care setting. The Ceribell System has been adopted by more than 450 active accounts, ranging from top academic centers to small community hospitals, and has been used to care for over 100,000 patients. 더 보기
SUNNYVALE, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients...
—Ms. Rodenbush to lead hiring and talent development initiatives— —Mr. Price to focus on market development and penetration— SUNNYVALE, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc...
SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients...
—Ceribell System stands to reduce costly ICU admissions and intra-facility patient transfers— —Military veterans face elevated risks of developing seizure disorders— SUNNYVALE, Calif., Nov. 11...
SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients...
Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024 PR Newswire SUNNYVALE, Calif., Oct. 29, 2024 SUNNYVALE, Calif., Oct. 29, 2024 /PRNewswire/ -- Ceribell, Inc. (Nasdaq:...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.67 | -7.35358872743 | 22.71 | 22.84 | 18.69 | 232094 | 20.28887649 | CS |
4 | -5.3 | -20.1214882308 | 26.34 | 28.23 | 18.69 | 326016 | 24.8163587 | CS |
12 | -5.53 | -20.8129469326 | 26.57 | 32.7489 | 18.69 | 212710 | 26.30014823 | CS |
26 | -2.22 | -9.54428202923 | 23.26 | 32.7489 | 18.69 | 256228 | 26.1612182 | CS |
52 | -2.22 | -9.54428202923 | 23.26 | 32.7489 | 18.69 | 256228 | 26.1612182 | CS |
156 | -2.22 | -9.54428202923 | 23.26 | 32.7489 | 18.69 | 256228 | 26.1612182 | CS |
260 | -2.22 | -9.54428202923 | 23.26 | 32.7489 | 18.69 | 256228 | 26.1612182 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관